Quarterly Reg.74(5) Compliance Certificate Submitted

Advik Laboratories (now renamed MPS Pharmaa Limited) has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 31 March 2026. The certificate, issued by the company's Registrar and Share Transfer Agent MAS Services Limited, confirms that all securities received for dematerialization from 1 January to 31 March 2026 were processed within the mandatory 15-day timeline. Mutilated share certificates were cancelled, the register of members updated, and stock exchanges informed within the prescribed period.